Genetic association of CHEK2, GSTP1, and ERCC1 with glioblastoma in the Han Chinese population

Tumor Biology

Volumn 35, Issue 5, 2014, Pages 4937-4941

  Dong, Yu Shu ^a,b   Hou, Wu Gang ^c   Li, Xiao Lan ^d   Jin, Tian Bo ^d   Li, Yue ^b   Feng, Da Yun ^a   Liu, De Bao ^b   Gao, Guo Dong ^a   Yin, Zhong Min ^b   Qin, Huai Zhou ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b The 463 Hospital of Chinese PLA   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d NORTHWEST UNIVERSITY   (China)

Author keywords

Case control study; CHEK2; ERCC1; Glioblastoma (GBM); GSTP1; Tag single nucleotide polymorphism(tSNP)

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CCL15 GENE; CCND1 GENE; CCNH GENE; CDKN1A GENE; CDKN2A GENE; CELL PROLIFERATION; CHAF1A GENE; CHEK2 GENE; CHINA; CONTROLLED STUDY; DNA DAMAGE; DNA METHYLATION; DNA POLYMORPHISM; ERBB2 GENE; ERCC1 GENE; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENOTYPE; GLIOBLASTOMA; GSTP1 GENE; HAN CHINESE; HUMAN; IRAK3 GENE; MAJOR CLINICAL STUDY; MALE; MGMT GENE; MKNK2 GENE; PRIORITY JOURNAL; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE; BRAIN TUMOR; ETHNOLOGY; GENETICS; METABOLISM;

CHECKPOINT KINASE 2; CHEK2 PROTEIN, HUMAN; DNA BINDING PROTEIN; ENDONUCLEASE; ERCC1 PROTEIN, HUMAN; GLUTATHIONE TRANSFERASE P1; GSTP1 PROTEIN, HUMAN; REACTIVE OXYGEN METABOLITE;

BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CHECKPOINT KINASE 2; CHINA; DNA-BINDING PROTEINS; ENDONUCLEASES; FEMALE; GLIOBLASTOMA; GLUTATHIONE S-TRANSFERASE PI; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; REACTIVE OXYGEN SPECIES;

EID: 84902993383     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1648-z     Document Type: Article

References (28)

1. Liu Y, Shete S, Etzel CJ, Scheurer M, Alexiou G, Armstrong G, et al. Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival. J Clin Oncol. 2010;28:2267-74.
2. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin. 2010;60:166-93.
3. Haque A, Banik NL, Ray SK. Molecular alterations in glioblastoma: potential targets for immunotherapy. Prog Mol Biol Transl Sci. 2011;98:187-234.
4. Schwartzbaum JA, Xiao Y, Liu Y, Tsavachidis S, Berger MS, Bondy ML, et al. Inherited variation in immune genes and pathways and glioblastoma risk. Carcinogenesis. 2010;31:1770-7.
5. Bethke L, Webb E, Murray A, Schoemaker M, Johansen C, Christensen HC, et al. Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma. Hum Mol Genet. 2008;17:800-5. (Pubitemid 351359696)
6. Rajaraman P, Wang SS, Rothman N, Brown MM, Black PM, Fine HA, et al. Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer Epidemiol Biomarkers Prev. 2007;16:1655-61. (Pubitemid 47294834)
7. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet. 2009;41:899-904.
8. Andersson U, Schwartzbaum J, Wiklund F, Sjostrom S, Liu Y, Tsavachidis S, et al. A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk. Acta Oncol. 2010;49:767-75.
9. Rajaraman P, Brenner AV, Butler MA, Wang SS, Pfeiffer RM, Ruder AM, et al. Common variation in genes related to innate immunity and risk of adult glioma. Cancer Epidemiol Biomarkers Prev. 2009;18:1651-8.
10. Liu Y, Shete S, Hosking F, Robertson L, Houlston R, Bondy M. Genetic advances in glioma: susceptibility genes and networks. Curr Opin Genet Dev. 2010;20:239-44.
11. Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, Lin WM, et al. High-throughput oncogene mutation profiling in human cancer. Nat Genet. 2007;39:347-51. (Pubitemid 46328493)
12. 2 for comparison of 2 independent examples. Cesk Zdrav. 1964;12:613-9.
13. Sole X, Guino E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006;22:1928-9. (Pubitemid 44283043)
14. Bland JM, Altman DG. Statistics notes. The odds ratio. BMJ. 2000;320:1468. (Pubitemid 30311684)
15. Cox DG, Hankinson SE, Hunter DJ. The erbB2/ HER2/neu receptor polymorphism Ile655Val and breast cancer risk. Pharmacogenet Genomics. 2005;15:447-50. (Pubitemid 41017592)
16. Xiang S, Sun Z, He Q, Yan F, Wang Y, Zhang J. Aspirin inhibits ErbB2 to induce apoptosis in cervical cancer cells. Med Oncol. 2010;27:379-87.
17. Zhou RM, Niu CX, Wang N, Chen ZF, Lei SE, Li Y. ERCC1 gene + 262A/C polymorphism associated with risk of gastric cardiac adenocarcinoma in nonsmokers. Arch Med Res. 2012;43:67-74.
18. Zhang LQ, Wang J, Xu L, Zhou JN, Guan X, Jiang F, et al. Nucleotide excision repair gene ERCC1 polymorphisms contribute to cancer susceptibility: a meta-analysis. Mutagenesis. 2012;27:67-76.
19. Ogino S, Hazra A, Tranah GJ, Kirkner GJ, Kawasaki T, Nosho K, et al. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer. Carcinogenesis. 2007;28:1985-90. (Pubitemid 47514483)
20. Doecke J, Zhao ZZ, Pandeya N, Sadeghi S, Stark M, Green AC, et al. Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma. Int J Cancer. 2008;123:174-80. (Pubitemid 351705206)
21. Weischer M, Bojesen SE, Ellervik C, Tybjaerg-Hansen A, Nordestgaard BG. CHEK2*1100de1C genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls. J Clin Oncol. 2008;26:542-8. (Pubitemid 351264346)
22. Kleibl Z, Havranek O, Hlavata L, Novotny J, Sevcik J, Pohlreich P, et al. The CHEK2 gene L157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population. Eur J Cancer. 2009;45:618-24.
23. Xu Z, Zhu H, Luk JM, Wu D, Gu D, Gong W, et al. Clinical significance of SOD2 and GSTP1 gene polymorphisms in Chinese patients with gastric cancer. Cancer. 2012;118:5489-96.
24. Li G, Jin TB, Wei XB, He SM, Liang HJ, Yang HX, et al. Selected polymorphisms of GSTP1 and TERT were associated with glioma risk in Han Chinese. Cancer Epidemiol. 2012;36:525-7.
25. Custodio AC, Almeida LO, Pinto GR, Santos MJ, Almeida JR, Clara CA, et al. GSTP1 Ile105Val polymorphism in astrocytomas and glioblastomas. Genet Mol Res. 2010;9:2328-34.
26. Yang ZH, Dai Q, Kong XL, Yang WL, Zhang L. Association of ERCC1 polymorphisms and susceptibility to nasopharyngeal carcinoma. Mol Carcinog. 2009;48:196-201.
27. McKean-Cowdin R, Barnholtz-Sloan J, Inskip PD, Ruder AM, Butler M, Rajaraman P, et al. Associations between polymorphisms in DNA repair genes and glioblastoma. Cancer Epidemiol Biomarkers Prev. 2009;18:1118-26.
28. Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, Decker PA, et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet. 2009;41:905-8.